![Ca-125 in Ovarian Cancer: To Test or Not to Test? – Latest and Best Treatments in Oncology & Radiotherapy Ca-125 in Ovarian Cancer: To Test or Not to Test? – Latest and Best Treatments in Oncology & Radiotherapy](https://drbhnglatest.files.wordpress.com/2017/09/screen-shot-2018-06-11-at-10-05-53-pm.png?w=1108)
Ca-125 in Ovarian Cancer: To Test or Not to Test? – Latest and Best Treatments in Oncology & Radiotherapy
![CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22026-1/MediaObjects/41598_2022_22026_Fig1_HTML.png)
CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a41774d54ed2429de098b01664d00db2774149da/6-Figure2-1.png)
PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar
Ovacome - The Ovarian Cancer Support Charity - Ovarian cancer is currently investigated using a blood test to measure levels of CA125, a protein in the blood which can be raised due
![JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis](https://www.mdpi.com/jcm/jcm-08-00607/article_deploy/html/images/jcm-08-00607-g001.png)
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study | PLOS Medicine
![Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry](https://pubs.acs.org/cms/10.1021/acs.analchem.3c00273/asset/images/medium/ac3c00273_0008.gif)